Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis

Parasitology Research

Volumn 92, Issue 6, 2004, Pages 478-483

  Pyrrho, Alexandre S ^a   Lenzi, Henrique Leonel ^b   Ramos, Juliene Antonio ^a   Moura Neto, Roberto ^a   Cachem, Fabio Christiane O F ^a   Santos Da Silva, Célia ^a   Takiya, Christina Maeda ^a   Gattass, Cerli Rocha ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EOSINOPHILIA; FEMALE; HEMATOCRIT; HEMOGLOBIN DETERMINATION; HEPATOMEGALY; HISTOPATHOLOGY; LIVER GRANULOMA; MORBIDITY; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL; RETICULOCYTE COUNT; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SPLENOMEGALY;

ANIMALIA; MURINAE; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 2442676366     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-004-1078-8     Document Type: Article

References (38)

1. Abdel-Wahab MF, Strickland GT (1993) Abdominal ultrasonography for assessing morbidity from schistosomiasis. 2. Hospital studies. Trans R Soc Trop Med Hyg 87:135-137
2. Adewusi OI, Nix NA, Lu X, Colley DG, Secor WE (1996) Schistosoma mansoni: relationship of tumor necrosis factor-alpha to morbidity and collagen deposition in chronic experimental infection. Exp Parasitol 84:115-123
3. Andrade ZA (1962) Aspectos experimentais da esplenomegalia da esquistossomose. Rev Inst Med Trop SP 4:249-255
4. Andrade ZA (1965) Hepatic schistosomiasis: morphological aspects. In: Popper HS (ed) Progess in liver disease. Grune and Stratton, New York, pp 228-242
5. Andrade ZA, Bina JC (1983) The pathology of the hepatosplenic form of schistosomiasis mansoni in its advanced form (study of 232 complete necropsies). Mem Inst Oswalde Cruz 78:285-305
6. Andrade ZA, Bina JC (1985) The changing pattern of pathology due to Schistosoma mansoni infection. Mem Inst Oswaldo Cruz 80:363-366
7. Bagshawe A (1970) A comparative study of hypersplenism in reactive and congestive splenomegaly. Br J Haematol 19:729-737
8. Bina JC, Prata A (1983) Reversão da hepatoesplenomegalia pelo tratamento específico da esquistossomose. Rev Soc Bras Med Trop 10:214-218
9. Borojevic R, Santos da Silva C, Carvalho EA (1983) Chronic schistosomiasis mansoni: splenic myelopoiesis and inhibition of neutrophil granulocytopoiesis mediated by the sera of patients. J Infect Dis 148:422-426
10. Bosshardt SC, Freeman GLJr, Secor WE, Colley DG (1997) IL-10 deficit correlates with chronic, hypersplenomegaly syndrome in male CBA/J mice infected with Schistosoma mansoni. Parasite Immunol 19:347-353
11. Botros SS, Makary EA, Ahmed KM, Ibrahim AM, Nashed NN, El-Nahal HM, Doughty BL, Hassanein HI (2000) Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine schistosomiasis mansoni. Int J Immunopharmacol 22:979-988
12. Cheever AW, Dunn MA, Dean DA, Duvall RH (1983) Differences in hepatic fibrosis in ICR, C3H, and C57BL/6 mice infected with Schistosoma mansoni. Am J Trop Med Hyg 32:1364-1369
13. Cheever AW, Duvall RH, Hallack TAJr, Minker RG, Malley JD, Malley KG (1987) Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. Am J Trop Med Hyg 37:85-97
14. Cheever AW, Jankovic D, Yap GS, Kullberg MC, Sher A, Wynn TA (1998) Role of cytokines in the formation and downregulation of hepatic circumoval granulomas and hepatic fibrosis in Schistosoma mansoni-infected mice. Mem Inst Oswaldo Cruz 93 [Suppl 1]:25-32
15. Cheever AW, Lenzi JA, Lenzi HL, Andrade ZA (2002) Experimental models of Schistosoma mansoni infection. Mem Inst Oswaldo Cruz 97:917-940
16. De Clercq D, Vercruysse J, Verle P, Kongs A, Diop M (2000) What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections? Trop Med Int Health 5:744-746
17. Dolber PC, Spach MS (1993) Conventional and confocal fluorescence microscopy of collagen fibers in the heart. J Histochem Cytochem 41:465-469
18. Druilhe P, Hagan P, Rook GA (2002) The importance of models of infection in the study of disease resistance. Trends Microbiol 10:S38-46
19. Eberl M, Langermans JA, Frost PA, Vervenne RA, Van Dam GJ, Deelder AM, Thomas AW, Coulson PS, Wilson RA (2001) Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees. Infect Immun 69:5352-5362
20. Fanning MM, Peters PA, Davis RS, Kazura JW, Mahmoud AA (1981) Immunopathology of murine infection with Schistosoma mansoni: relationship of genetic background to hepatosplenic disease and modulation. J Infect Dis 144:148-153
21. Garba A, Tohon Z, Sidiki A, Chippaux JP, De Chabalier F (2001) Efficacity of praziquantel in school-aged children in a hyperendemic zone for Schistosoma haematobium (Niger, 1999). Bull Soc Pathol Exot 94:42-45
22. Guyatt HL, Brooker S, Kihamia CM, Hall A, Bundy DA (2001) Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of Tanzania. Bull World Health Organ 79:695-703
23. Hagan P, Ndhlovu P, Dunne D (1998) Schistosome immunology: more questions than answers. Parasitol Today 14:407-412
24. Henderson GS, Nix NA, Montesano MA, Gold D, Freeman GLJr, McCurley TL, Colley DG (1993) Two distinct pathological syndromes in male CBA/J inbred mice with chronic Schistosoma mansoni infections. Am J Pathol 142:703-714
25. Homeida MA, El Tom I, Nash T, Bennett JL (1991) Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg 45:360-365
26. Jamra M, Maspes V, Meira DA (1964) Types and mechanisms of anemia in schistosomiasis mansoni. Rev Inst Med Trop SP 6:126-136
27. Kariuki HC, Mbugua G, Magak P, Bailey JA, Muchiri EM, Thiongo FW, King CH, Butterworth AE, Ouma JH, Blanton RE (2001) Prevalence and familial aggregation of schistosomal liver morbidity in Kenya: evaluation by new ultrasound criteria. J Infect Dis 183:960-966.
28. Kongs A, Verle P, Dieng A, Talla I, Rouquet P (1996) Clinical investigation of a population recently infected with Schistosoma mansoni (Richard-Toll, Senegal). Trop Med Int Health 1:191-198
29. Lambertucci JR, Modha J, Curtis R, Doenhoff M (1989) The association of steroids and schistosomicides in the treatment of experimental schistosomiasis. Trans R Soc Trop Med Hyg 83:354-357
30. Lambertucci JR, Rayes AA, Serufo JC, Nobre V (2001) Pyogenic abscesses and parasitic diseases. Rev Inst Med Trop Sao Paulo 43:67-74
31. Pyrrho AS, Ramos JA, Neto RM, Silva CS, Lenzi HL, Takiya CM, Gattass CR (2002) Dexamethasone, a drug for attenuation of Schistosoma mansoni infection morbidity. Antimicrob Agents Chemother 46:3490-3498
32. Raso P, Bogliolo L (1970) Patologia. In: Cunha ASD (ed) Esquistossomose mansoni. Sarvier and USP, São Paulo, pp 77-130
33. Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM, McManus DP (2002) Schistosomiasis. N Engl J Med 346:1212-1220
34. Santos da Silva C, Carvalho EA, Goncalvez MS, Borojevic R (1988) Experimental murine schistosomiasis mansoni: inhibition of neutrophil granulocyte inflammatory reaction. Braz J Med Biol Res 21:273-279
35. Utzinger J, N'Goran EK, N'Dri A, Lengeler C, Tanner M (2000) Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Trop Med Int Health 5:771-778
36. Warren KS, Domingo EO, Cowan RB (1967) Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol 51:735-756
37. Woodruff AW, Shafei AZ, Awwad HK, Pettitt LE, Abaza HH (1966) Anaemia in patients with schistosomiasis and gross splenomegaly. Trans R Soc Trop Med Hyg 60:343-351
38. World Health Organisation (1997) Schistosomiasis. Tropical Disease Research: Progress 1995-1996, 13th Programme Report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases. World Health Organisation, Geneva, pp 62-73